199 related articles for article (PubMed ID: 36521927)
1. Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch.
Cornel AM; Dunnebach E; Hofman DA; Das S; Sengupta S; van den Ham F; Wienke J; Strijker JGM; van den Beemt DAMH; Essing AHW; Koopmans B; Engels SAG; Lo Presti V; Szanto CS; George RE; Molenaar JJ; van Heesch S; Dierselhuis MP; Nierkens S
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36521927
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic therapies for neuroblastoma: immunogenicity awakens.
Jiménez C; Moreno L; Segura MF
Mol Oncol; 2023 May; 17(5):718-721. PubMed ID: 36840349
[TBL] [Abstract][Full Text] [Related]
3. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA
Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492
[TBL] [Abstract][Full Text] [Related]
4. A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.
Kroesen M; Nierkens S; Ansems M; Wassink M; Orentas RJ; Boon L; den Brok MH; Hoogerbrugge PM; Adema GJ
Int J Cancer; 2014 Mar; 134(6):1335-45. PubMed ID: 24038106
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.
Spel L; Boelens JJ; van der Steen DM; Blokland NJ; van Noesel MM; Molenaar JJ; Heemskerk MH; Boes M; Nierkens S
Oncotarget; 2015 Nov; 6(34):35770-81. PubMed ID: 26452036
[TBL] [Abstract][Full Text] [Related]
6. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells.
Sun T; Li Y; Yang W; Wu H; Li X; Huang Y; Zhou Y; Du Z
J Cancer; 2019; 10(23):5638-5645. PubMed ID: 31737100
[No Abstract] [Full Text] [Related]
8. Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.
Ferrari de Andrade L; Kumar S; Luoma AM; Ito Y; Alves da Silva PH; Pan D; Pyrdol JW; Yoon CH; Wucherpfennig KW
Cancer Immunol Res; 2020 Jun; 8(6):769-780. PubMed ID: 32209637
[TBL] [Abstract][Full Text] [Related]
9. Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer.
Huang B; Sikorski R; Sampath P; Thorne SH
J Immunother; 2011 Apr; 34(3):289-96. PubMed ID: 21389869
[TBL] [Abstract][Full Text] [Related]
10. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
Frazao A; Rethacker L; Jeudy G; Colombo M; Pasmant E; Avril MF; Toubert A; Moins-Teisserenc H; Roelens M; Dalac S; Maubec E; Caignard A
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32912923
[TBL] [Abstract][Full Text] [Related]
11. [Expression of HLA class I molecules and MHC class I chain-related molecules A/B in K562 and K562/AO2 cell lines and their effects on cytotoxicity of NK cells].
Mei JZ; Niu XQ; Guo KY; Zhou J; Wei HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):288-91. PubMed ID: 17493333
[TBL] [Abstract][Full Text] [Related]
12. An epigenetic vaccine model active in the prevention and treatment of melanoma.
Khan AN; Magner WJ; Tomasi TB
J Transl Med; 2007 Dec; 5():64. PubMed ID: 18070359
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.
Khan AN; Gregorie CJ; Tomasi TB
Cancer Immunol Immunother; 2008 May; 57(5):647-54. PubMed ID: 18046553
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.
Aiken TJ; Erbe AK; Zebertavage L; Komjathy D; Feils AS; Rodriguez M; Stuckwisch A; Gillies SD; Morris ZS; Birstler J; Rakhmilevich AL; Sondel PM
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618290
[TBL] [Abstract][Full Text] [Related]
15. Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.
Yamanegi K; Yamane J; Kobayashi K; Kato-Kogoe N; Ohyama H; Nakasho K; Yamada N; Hata M; Nishioka T; Fukunaga S; Futani H; Okamura H; Terada N
Oncol Rep; 2010 Dec; 24(6):1621-7. PubMed ID: 21042760
[TBL] [Abstract][Full Text] [Related]
16. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
Pajtler KW; Rebmann V; Lindemann M; Schulte JH; Schulte S; Stauder M; Leuschner I; Schmid KW; Köhl U; Schramm A; Eggert A
Int J Cancer; 2013 Aug; 133(4):908-19. PubMed ID: 23400852
[TBL] [Abstract][Full Text] [Related]
17. Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.
Pace M; Williams J; Kurioka A; Gerry AB; Jakobsen B; Klenerman P; Nwokolo N; Fox J; Fidler S; Frater J;
PLoS Pathog; 2016 Aug; 12(8):e1005782. PubMed ID: 27529554
[TBL] [Abstract][Full Text] [Related]
18. The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.
Belicha-Villanueva A; Riddell J; Bangia N; Gollnick SO
Lasers Surg Med; 2012 Jan; 44(1):60-8. PubMed ID: 22246985
[TBL] [Abstract][Full Text] [Related]
19. Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells.
Xiao W; Dong W; Zhang C; Saren G; Geng P; Zhao H; Li Q; Zhu J; Li G; Zhang S; Ye M
Eur J Med Res; 2013 Dec; 18(1):61. PubMed ID: 24359553
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.
Tiper IV; Webb TJ
Cancer Immunol Immunother; 2016 Nov; 65(11):1411-1421. PubMed ID: 27614429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
